Medicine and Dentistry
Magnetic Resonance Imaging
100%
Cancer
65%
Magnetic Resonance Imaging of Breast
58%
Biopsy
46%
Mammography
44%
Breast Imaging - Reporting And Data System
36%
Digital Breast Tomosynthesis
34%
Breast Cancer
29%
Breast Cancer Screening
29%
Isotopes of Calcium
29%
High Risk Screening
29%
Tomosynthesis
29%
Malignant Neoplasm
23%
Cardiovascular Disease
22%
Mammogram
19%
Retrospective Cohort Study
19%
Breast Biopsy
18%
Metastatic Carcinoma
14%
Tattoo
14%
Coronary Artery
14%
Cohort Study
14%
Cardiovascular System
14%
Axillary Lymph Node
14%
Artery
14%
Neoadjuvant Chemotherapy
14%
Retrospective Study
10%
Positron Emission Tomography
9%
Metastatic Breast Cancer
9%
Outpatient
9%
Computer Assisted Tomography
9%
Multivariate Analysis
9%
Breast Tumor
8%
Receptor
7%
Sentinel Lymph Node Biopsy
6%
Lymph Node
6%
Sentinel Node
6%
Intraductal Carcinoma
6%
Cardiovascular Disease Prevention
5%
Real-Time MRI
5%
Diagnosis
5%
Cancer Diagnosis
5%
Pathophysiology
5%
Keyphrases
Malignancy Rate
43%
Breast MRI
32%
Architectural Distortion
29%
Tomosynthesis
29%
Non-visualization
29%
Malignancy
27%
Vacuum-assisted Biopsy
23%
Digital Breast Tomosynthesis
23%
Sonographic
20%
High-risk Lesions
17%
MRI-guided Biopsy
17%
Core Needle Biopsy
17%
Retrospective Cohort Study
16%
MRI Biopsy
14%
Preoperative Localization
14%
Breast
14%
Breast Cancer
14%
Patient Utilization
14%
Breast Imaging
14%
Tattoo Ink
14%
Retrospective Review
14%
Risk Screening
14%
Breast Arteries
14%
Guided Biopsy
14%
Saving Time
14%
Mammogram
14%
Breast Magnetic Resonance Imaging
14%
Implications for Management
14%
Axillary Lymph Node
14%
MRI-guided
14%
Pathological Response
14%
Extracolonic Malignancy
14%
Pathological Complete Response
14%
Data Systems
14%
Coronary Artery Calcium Score
14%
Abbreviated Protocol
14%
Screening Mammography
14%
Screening MRI
14%
Reporting System
14%
Image Features
14%
Circumscribed Masses
14%
Coronary Artery Calcium
14%
Observational Cohort Study
14%
Neoadjuvant Chemotherapy
14%
Upgrade Rate
14%
Breast Cancer Screening
14%
MRI Features
14%
High Risk
14%
Atypical Ductal Hyperplasia
11%
Breast Mass
10%